Table 1 summarizes the results of DAPK protein expression in patients with central neurocytoma and oligodendroglioma. A high level of DAPK protein expression was common in oligodendroglioma and was seen in 90% of patients. In contrast, only 38.5% of samples from central neurocytoma displayed high levels of DAPK protein expression. However, this difference observed between central neurocytoma and oligodendroglioma was not statistically significant (P = 0.054). The gene discussed is DAPK1; the disease is oligodendroglioma.